3 results match your criteria: "and Northeast Program Evaluation Center[Affiliation]"
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.
JAMA
May 2014
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York8New York State Psychiatric Institute, New York, New York.
Importance: Long-acting injectable antipsychotics are used to reduce medication nonadherence and relapse in schizophrenia-spectrum disorders. The relative effectiveness of long-acting injectable versions of second-generation and older antipsychotics has not been assessed.
Objective: To compare the effectiveness of the second-generation long-acting injectable antipsychotic paliperidone palmitate with the older long-acting injectable antipsychotic haloperidol decanoate.
Impact of medical comorbidity on the quality of schizophrenia pharmacotherapy in a national VA sample.
Med Care
January 2006
Department of Psychiatry, Yale School of Medicine, New Haven 06519, and Northeast Program Evaluation Center, VA Connecticut Healthcare System, West Haven, Connecticut, USA.
Background: More than half of patients with schizophrenia have comorbid chronic medical illness. During the past decade, several studies have evaluated the quality of the medical treatment of these conditions. This work examines the impact of comorbid medical conditions on the quality of schizophrenia pharmacotherapy in the Department of Veterans Affairs (VA).
View Article and Find Full Text PDFMental disorders and quality of care among postacute myocardial infarction outpatients.
J Nerv Ment Dis
January 2002
Mental Illness Research, Education, and Clinical Center and Northeast Program Evaluation Center, VA Connecticut Healthcare System, West Haven 06516, USA.